Moreira, D. M., Presti, J. C., Aronson, W. J., Terris, M. K., Kane, C. J., Amling, C. L., . . . Freedland, S. J. (2010). Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.

Moreira, Daniel M., Joseph C. Presti, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Leon L. Sun, Judd W. Moul, ja Stephen J. Freedland. Postoperative Prostate-specific Antigen Nadir Improves Accuracy for Predicting Biochemical Recurrence After Radical Prostatectomy: Results From the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center Databases. 2010.

Moreira, Daniel M., et al. Postoperative Prostate-specific Antigen Nadir Improves Accuracy for Predicting Biochemical Recurrence After Radical Prostatectomy: Results From the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center Databases. 2010.